Theranostics Market
Theranostics Market - Global Industry Assessment & Forecast
#
Pages:
196
Base Year:
2023
Apr - 2024
Format:
Report Code:
VMR-2451
Segments Covered
By
Products Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software & Services
-
By
Application Prostate Cancer, Bone Metastasis, Other Applications
-
By
End User Hospitals & Cancer Care Centers, Theranostics Centers, Research & Academic Centers
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 2091 Million |
 Revenue 2032:
|
USD 6805.1 Million |
 Revenue CAGR
(2024 - 2032): |
14% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Theranostics Market Segment Analysis
- Theranostics Products Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Theranostics Application Outlook (Revenue, USD Million, 2018 - 2030)
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Theranostics End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
-
North America Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
-
North America Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- U.S.
- U.S. Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- U.S. Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- U.S. Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- U.S. Theranostics Market, by Products
- Canada
- Canada Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Canada Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Canada Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Canada Theranostics Market, by Products
-
Mexico
- Mexico Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Mexico Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Mexico Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Mexico Theranostics Market, by Products
-
North America Theranostics Market, by Products
- Europe
-
Europe Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
-
Europe Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
-
Europe Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- U. K.
- U.K. Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- U.K. Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- U.K. Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- U.K. Theranostics Market, by Products
- France
- France Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- France Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- France Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- France Theranostics Market, by Products
-
Germany
- Germany Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Germany Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Germany Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Germany Theranostics Market, by Products
-
Italy
- Italy Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Italy Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Italy Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Italy Theranostics Market, by Products
-
Spain
- Spain Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Spain Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Spain Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Spain Theranostics Market, by Products
-
Rest of Europe
- Rest of Europe Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Rest of Europe Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Rest of Europe Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Rest of Europe Theranostics Market, by Products
-
Europe Theranostics Market, by Products
- Asia Pacific
-
Asia Pacific Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
-
Asia Pacific Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
-
Asia Pacific Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- China
- China Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- China Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- China Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- China Theranostics Market, by Products
- Japan
- Japan Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Japan Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Japan Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Japan Theranostics Market, by Products
-
Germany
- Germany Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Germany Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Germany Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Germany Theranostics Market, by Products
-
India
- India Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- India Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- India Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- India Theranostics Market, by Products
-
South Korea
- South Korea Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- South Korea Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- South Korea Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- South Korea Theranostics Market, by Products
-
South East Asia
- South East Asia Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- South East Asia Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- South East Asia Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- South East Asia Theranostics Market, by Products
-
Rest of Asia Pacific
- Rest of Asia Pacific Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Rest of Asia Pacific Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Rest of Asia Pacific Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Rest of Asia Pacific Theranostics Market, by Products
-
Asia Pacific Theranostics Market, by Products
- Latin America
-
Latin America Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
-
Latin America Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
-
Latin America Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Brazil
- Brazil Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Brazil Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Brazil Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Brazil Theranostics Market, by Products
- Argentina
- Argentina Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Argentina Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Argentina Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Argentina Theranostics Market, by Products
-
Rest of Latin America
- Rest of Latin America Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Rest of Latin America Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Rest of Latin America Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Rest of Latin America Theranostics Market, by Products
-
Latin America Theranostics Market, by Products
- Middle East & Africa
-
Middle East & Africa Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
-
Middle East & Africa Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
-
Middle East & Africa Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- GCC Countries
- GCC Countries Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- GCC Countries Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- GCC Countries Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- GCC Countries Theranostics Market, by Products
- South Africa
- South Africa Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- South Africa Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- South Africa Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- South Africa Theranostics Market, by Products
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Theranostics Market, by Products
- Diagnostic Imaging
- Radiopharmaceuticals
- IVD/Biomarker Screening
- Software & Services
- Rest of Middle East & Africa Theranostics Market, by Application
- Prostate Cancer
- Bone Metastasis
- Other Applications
- Rest of Middle East & Africa Theranostics Market, by End User
- Hospitals & Cancer Care Centers
- Theranostics Centers
- Research & Academic Centers
- Rest of Middle East & Africa Theranostics Market, by Products
-
Middle East & Africa Theranostics Market, by Products
- North America
Vantage Market
Research | 09-Apr-2024
FAQ
Frequently Asked Question
What is the global demand for Theranostics in terms of revenue?
-
The global Theranostics valued at USD 2091 Million in 2023 and is expected to reach USD 6805.1 Million in 2032 growing at a CAGR of 14%.
Which are the prominent players in the market?
-
The prominent players in the market are GE Healthcare Technologies (U.S.), BAMF Health (U.S.), Siemens Healthcare AG (Germany), Canon Medical Systems Corporation (Japan), Curasight (Denmark), Cardinal Health Inc. (U.S.), Radiopharm Theranotics Ltd. (Australia), Clarity Pharmaceuticals Ltd. (Australia), Point Biopharma Global Inc. (U.S.), Nuview Life Sciences (U.S.),.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 14% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Theranostics include
- Increasing Demand for Personalized Medicine due to the understanding that individuals respond uniquely to treatments based on their genetic makeup, disease characteristics, and lifestyle factors
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Theranostics in 2023.
